Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.

  • 1 September 1986
    • journal article
    • Vol. 31  (9) , 801-3
Abstract
The long-acting injectable progestogen Depo-Provera appears to substantially reduce women's susceptibility to recurrent vulvovaginal candidiasis. Pregnancy and exogenous estrogen appear to counteract this effect of the drug. Evidence was derived from 15 patients studied for up to six years.

This publication has 0 references indexed in Scilit: